EMDR treatment for anxiety related to the future in MS patients

EMDR treatment for anxiety related to the future in MS patients - EMDR treatment for anxiety in MS patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON45157

Enrollment

Registered

2015-12-01

Start date

2016-01-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety and Multiple Sclerosis

Interventions

Patients will randomly be assigned to getting EMDR treatment (EMDR ff) or Supportive Listening (SL).

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: diagnosis Multiple Sclerosis Dutch speaking adult (18+) HADS-A score 8 or higher anxiety related to the future

Exclusion criteria

Exclusion criteria: severe psychiatric comorbidity; i.e. dissociation, high suicide risk following other psychological treatment at the same time

Design outcomes

Primary

Measure	Time frame
Hypothesis 1: Anxiety scores on the hospital anxiety and depression scale (HADS-A). Penn State Worry Questionnaire (PSWQ) scores. Scores on Quality of Life questionnaire: World Health Organisation Quality of Life (WHOQOL-bref).	—

Secondary

Measure	Time frame
Hypothesis 2: Scores on the Montreal Cognitive Assesment (MoCA) and the Symbol Digit Modalities Test (SDMT) Scores on Cognitive Avoidance Questionnaire (CAQ)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)